Overdose Prevention Centers and Behavioral Health
ConditionOverdose
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNYU Langone Health
About this trial
The aims of this study are: (Aim 1) Identify sources of heterogeneous impacts of opioid prevention center (OPC) use on non-fatal and fatal overdose risk among individuals with histories of polysubstance use (PSU); (Aim 2) Estimate the impact of OPC use on treated psychiatric events among clients with histories of PSU, and; (Aim 3) Assess the barriers and facilitators of integrating mental health services into existing syringe service and OPC delivery models.
Eligibility criteria
Qualifiers
are 18 years of age or older;
engaged in syringe service program and/or overdose prevention center services in New York City in the past 30 days before the date of enrollment;
are able to complete assessments in English or Spanish;
are competent to give written informed consent at the time of the interview;
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
500 Participants
are grouped into 2 trial groupsSponsors and collaborators
NYU Langone Health
Lead sponsor
Centers for Disease Control and Prevention
Collaborator
Source ClinicalTrials.gov